Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
CD34+ cells obtained from good mobilizers are more activated and exhibit lower ex vivo expansion efficiency than their counterparts from poor mobilizers
Transfusion, 10/26/09
Ivanovic Z et al. – A good response to G–CSF mobilization treatment is associated with a higher degree of proliferative and metabolic activation of mobilized CD34+ cells with a decrease in their expansion capacity.
Today in Transfusion Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
British Journal of Haematology, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


